Corline Biomedical (Sweden) Probability of Future Stock Price Finishing Over 21.55
| CLBIO Stock | SEK 7.24 0.16 2.26% |
Corline |
Corline Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Corline Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Corline Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Corline Biomedical generated a negative expected return over the last 90 days | |
| Corline Biomedical has high historical volatility and very poor performance | |
| Corline Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 7.06 M. Net Loss for the year was (6.92 M) with profit before overhead, payroll, taxes, and interest of 9.1 M. | |
| Corline Biomedical AB has accumulated about 41.63 M in cash with (4.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45. | |
| Roughly 55.0% of the company shares are held by company insiders |
Corline Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Corline Stock often depends not only on the future outlook of the current and potential Corline Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Corline Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.4 M | |
| Cash And Short Term Investments | 41.6 M |
Corline Biomedical Technical Analysis
Corline Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. Corline Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Corline Biomedical AB. In general, you should focus on analyzing Corline Stock price patterns and their correlations with different microeconomic environments and drivers.
Corline Biomedical Predictive Forecast Models
Corline Biomedical's time-series forecasting models is one of many Corline Biomedical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Corline Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Corline Biomedical
Checking the ongoing alerts about Corline Biomedical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Corline Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Corline Biomedical generated a negative expected return over the last 90 days | |
| Corline Biomedical has high historical volatility and very poor performance | |
| Corline Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 7.06 M. Net Loss for the year was (6.92 M) with profit before overhead, payroll, taxes, and interest of 9.1 M. | |
| Corline Biomedical AB has accumulated about 41.63 M in cash with (4.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45. | |
| Roughly 55.0% of the company shares are held by company insiders |
Additional Tools for Corline Stock Analysis
When running Corline Biomedical's price analysis, check to measure Corline Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corline Biomedical is operating at the current time. Most of Corline Biomedical's value examination focuses on studying past and present price action to predict the probability of Corline Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corline Biomedical's price. Additionally, you may evaluate how the addition of Corline Biomedical to your portfolios can decrease your overall portfolio volatility.